http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014205159-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_51ffc2be14ee7ff862b8333a528a6893
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5383
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5383
filingDate 2014-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f419d6b8a0dbba4aec46bd0fa1a8d77
publicationDate 2014-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2014205159-A1
titleOfInvention Poloxamer based inhalation composition
abstract An inhalation composition for the treatment of bacteria related diseases is provided. The disclosed composition may include a mixture of three or more API(s) and a micronized poloxamer composition. Micronized poloxamer composition may include poloxamer 188 and poloxamer 407. According to an embodiment, an inhalation composition including one or more APIs may be delivered to the respiratory tract by employing inhalation devices, such as inhalers and nebulizers. Antibiotic inhalation composition may provide improved solubility and bioavailability for three or more API(s), such as levofloxacin, betamethasone, and clindamycin. Furthermore, the synergistic effect of micronized poloxamer composition may provide improved solubility and bioavailability of any suitable API.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11701426-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11684567-B2
priorityDate 2013-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008200442-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006115535-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007181133-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011008266-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9782
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127998401
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6087
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127888046
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11094963
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395403
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446598
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405795
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127631680
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID149096
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396797
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396542
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID146364
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226401373
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396541

Total number of triples: 37.